A
ALLO//CIK 0001737287
Allogene Therapeutics, Inc.
Market Data
$2.01−$0.14 (−6.51%)
ALLO · Last trade
Prev Close
$2.15
Range (30d)
$1.66 – $2.12
Recent Filings
- SCHEDULE 13G/A38.6 KBAllogene Therapeutics, Inc.Aug 7, 8:20 PM ET·0001296549-26-000008
- SCHEDULE 13G8.0 KBAllogene Therapeutics, Inc.Aug 7, 8:33 AM ET·0000093751-26-000405
- 8-K221.2 KBAllogene Therapeutics, Inc.Jun 22, 4:05 PM ET·0001628280-26-044618
- 8-K140.2 KBAllogene Therapeutics, Inc.May 28, 5:06 PM ET·0001193125-26-245484
- 10-Q6.9 MBAllogene Therapeutics, Inc.May 13, 4:05 PM ET·0001628280-26-034585
- 8-K225.4 KBAllogene Therapeutics, Inc.May 13, 4:03 PM ET·0001628280-26-034583
- 8-K453.4 KBAllogene Therapeutics, Inc.Apr 15, 4:35 PM ET·0001193125-26-157140
- 8-K133.5 KBAllogene Therapeutics, Inc.Apr 13, 4:09 PM ET·0001193125-26-152866
- 8-K168.9 KBAllogene Therapeutics, Inc.Apr 13, 7:45 AM ET·0001193125-26-151999
- 10-K11.9 MBAllogene Therapeutics, Inc.Mar 12, 4:11 PM ET·0001628280-26-017242
Insiders
10- Amado RafaelEVP of R&D
- Barrett Elizabeth A.Director
- Belldegrun ArieDirector
- Beneski Benjamin MachinasSVP, Chief Technical Officer
- Bhavnagri VeerGeneral Counsel
- BONDERMAN DAVIDDirector, 10% Owner
- Chang David DDirector, President and CEO
- CHEN YINLIN JACKSVP, Finance
- COULTER JAMES G10% Owner
- DEYOUNG JOHN A.Director
Tickers
Addresses
business
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080